. Brachyury knockdown significantly inhibited cell migration and invasion and suppressed chemoresistance. A quantitative PCR array of drug transporter genes revealed that knockdown of Brachyury ��u��� ��w� ���u������ �f ATP-b������ �������� �����p����� �����. Fu���������, ACCS-M GFP radioresistance was significantly suppressed by Brachyury k���k��w�. K���k��w� �f Brachyury significantly �������z�� ACCS-M GFP ����� �� ���������������p�. T��� ��u�� ������������ ���� Brachyury knockdown reduces invasiveness ��� ��������������� ��� ��������������� �f CSC� in vivo. T����f���, Brachyury k���k��w� ��� b� � u��fu� �����p�u��� tool for sensitizing CSCs to conventional chemoradiotherapy.
Introduction
A������ ������ ��������� �A�CC� �� ����� ��� ���� ������ malignant tumors of the salivary glands and is characterized by unique clinical features and behavior. Although slow ���w���, A�CC �p����� ������������ ���� ��j����� ����u��. I� ������� � ���� ���k �f ���u������ ��� ������� ����������, w��� 40-60% of afflicted patients developing distant metastases �� ��� �u���, b���, ��� ��f� ����u�� �1,2�. A�CC �� ��������� �� ����������p� ��� ����������p�. T����f���, ���������-��������� distant metastases remain a significant obstacle to the long-���� �u�� �f p������� w��� A�CC, ��p����z��� ��� ���� f�� ����-���������� �����p� f�� A�CC.
We previously established 3 AdCC cell lines that express ����� f�u�������� p������ �GFP� f��� ��� ACCS ���� ���� u���� �������p�� �����p��������� ��� in vivo ��������� �� ��� nude mouse. These 3 lines include the parental ACCS GFP, ��� ������ �u��������� ACCS-T GFP, ��� ��� ���������� ACCS-M GFP ����. W� ������������ ���� ACCS-M GFP ����� �x��b���� � ���� �f E-�������� ��� ��������� ��� � ���� �� vimentin, suggesting that the epithelial-mesenchymal transition (EMT) is a key event in AdCC metastasis that induces tumor cell dissemination from the primary tumor site (3) . We also showed a direct correlation between EMT and prevalence �f ������ ���� ����-��k� ����� �� A�CC �4�.
T�� EMT p������ ��������� �u���� �u��� p���������� �pp���� �� b� ���������� b� �xp������� �f ����� ��b������ �����, ����u���� Twist, Snail, Slug, Goosecoid ��� SIP1 �5,6�. T�� ��������p���� f������ ������� b� ����� ����� ��p��� mesenchymal traits to tumor cells, including motility and invasiveness. For example, expression of Twist is elevated in various �������, ����u���� b�����, p�������, ������� ��� �������� �7�. I� ��������, ��� T-b�x ��������p���� f����� B�����u��, � p������ required for mesoderm formation during development (8) (9) (10) , ��p������� p������� EMT �� �u��� ��������� ���� ����� �11�. T�� ������ ��u�� ���� ���w�� ���� Brachyury overexpression �� �u��� ��������� ����� ���u��� ������� �������������� �f EMT. These findings suggest that the EMT in cancer cells is ���������� b� ���������� ������� �� ��� EMT �u���� ������ human development.
Other studies using neoplastic tissue have identified self����w���, ����-��k� ����� w����� �u����, ��f����� �� �� ������ ���� ����� �CSC��. CSC� �������u�� � �������� �f ���p������ cells within a tumor and are defined operationally by their ability to seed new tumors. For this reason, they have also These observations suggest that knocking down Brachyury ��� ������� CSC ��� EMT, ��u� ���u���� CSC ��ff����������� and sensitization to conventional chemotherapy and radiotherapy. In this study, we validated that Brachyury k���k��w� �upp������ �����-��� ��������������� in vitro as a first step in ����b������� ��� �����p�u��� p�������� ������� CSC�. Wound healing assay. Cells (3x10 5 � w��� ������ �� � 6-w��� p����. Af��� 24 �, 'w�u���' w��� ��������� w��� � 200-µ� pipette tip, washed with medium and observed under a fluorescence microscope (BZ-8000; Keyence, Osaka, Japan). The wound regions were photographed again after 8, 16 and 24 �, ��� ��� w�u�� ����� w��� ����u���. W�u�� ���� w�� ����u����� u���� ��� f����w��� f���u��: w�u�� ���� �% �f control) = (wound area after the indicated period x100)/initial w�u�� ����.
Materials and methods

Chemicals
Evaluation of tumor dissemination from the primary cancer nest. Evaluation of tumor dissemination from the primary cancer nest was performed as previously described (25) . Briefly, living ACCS cell lines were fluorescently labeled u���� V�b���� D�O ��� D�D ����-��b����� ���u����� �M����u��� P��b��, Eu����, OR, USA� ��������� �� ��� ���uf���u���'� �����u������. T���, 1x10 6 ��b���� ����� w��� p������� ��� ���u�p����� �� 10 µ� �������� ��p� I ��� �� f��� � ����� ���� ��u����. T�� ��������-��b����� �u��� ���� p������ w��� allowed to solidify for 30 min at 37˚C in a 100-µl microcentrifuge tube; the pellets were then embedded in non-labeled fibroblasts containing collagen type I gel (1x10 5 cells/ml) and solidified. Growth medium was placed over the collagen gels and cultured. Tumor dissemination was observed under a fluorescence microscope (BZ-8000; Keyence). The grade of �u��� ������������� f��� ��� �u��� ���� p����� ��������� ��� primary tumor nest) was evaluated by measuring the distance �f ��� ����� f��� ��� ���� �f ��� ���� �� 5 �������� ��������, standardized rectangular light fields (500x100 µm), and the values were summed. The evaluation was conducted twice ����� f�� 7 ����.
MTT assay. ACCS cell lines were seeded into CellTiter 96 Aqueous Non-radioactive Cell Proliferation Assay G4000 p����� �P������, M������, WI, USA� �� � ������� �f 5x10 3 ����� p�� w��� ��� ���ub���� �� DMEM ���������� 10% FBS f�� 8 h. The medium was replaced with serum-free DMEM after 3 washes with PBS. For chemosensitivity analysis, a dilutional series of anticancer drugs was applied at final drug concen-�������� �f 0, 0.001, 0.01, 0.1, 1, 10, 100 ��� 1,000 µM ��� incubated for 24 h in a humidified incubator under an atmo�p���� �f 5% CO 2 at 37˚C. For radiosensitivity analysis, in vitro gamma-ray irradiation was administered at 5, 10, 15, or 30 Gy w��� � G�������� 40 ® Ex����� L�w D���-R��� R������� I��������� �B��� T�����������, O���w�, C������, ��� ����� w��� then incubated for 48 or 72 h in a humidified incubator under �� �����p���� �f 5% CO 2 at 37˚C. After incubation, ACCS cells were analyzed by CellTiter 96 Aqueous Non-radioactive C��� P����f������� A���� G4000 �P������� ��������� �� ��� ���uf���u���'� �����u������. T�� �b���b���� �f ���p��� �� 590 nm (A590) was measured with a microplate reader (Model 680, Bio-Rad, USA). All experiments were carried out in triplicate and repeated 3 times. D��� w��� �������z�� �� ��� u�������� �������� ��� reported as % viability. The IC 50 (µM) values for cyto toxicity �f ��� ���������� ��u� ��p������� ��� ������������� �������� 50% viability, which was determined from the concentrationviability curve. The concentration-viability curve was generated using a non-linear regression model with the Solver function of Microsoft Excel as previously described (26) .
Real-time RT-PCR. T���� RNA w�� �x������� f��� ACCS GFP ����� u���� ��� RN���� M��� k�� �Q�����, C����w����, CA, USA� ��� u��� f�� f����-������ �DNA ���������. T�� mRNA levels were quantified in triplicate using a real-time PCR ������ w��� ��� B�������� SYBR G���� qPCR k�� �S���������, L� J����, CA, USA� f�� Brachyury ��� Sox2 �� ��� RT 2 Profiler PCR Array (96-well format) for human drug �����p������ �Q������. Sp���f�� p������ f�� Brachyury ��� Sox2 were: hBrachyury (F) 5'-TGCTGCAATCCCATGACA-3' , (R) 5'-CGTTGCTCACAGACCACA-3'; hSOX2, (F) 5'-TGG GTTCGGTGGTCAAGT-3', (R) 5'-CTCTGGTAGTGCTG GGACA-3'. The PCR cycling conditions were 10 min at 95˚C followed by 47 cycles at 95˚C for 30 sec, 60˚C for 30 sec, and 72˚C for 60 sec. Dissociation curve analyses confirmed that ��� ������� ������p����� �� u��qu� ��p������. Exp������� levels were normalized to β-actin mRNA levels for each ���p�� �b������ f��� p������� ������ ��� �����z�� u���� ��� LightCycler software package version 3.5 (Roche Diagnostics, M�������, G������� f�� �B�����u�� ��� �SOX2 ��� Mx 3000P QPCR system (Agilent Technologies, CO, USA) for the RT 2 Profiler PCR Array.
Statistical analysis. A�� ���� ��� ��p�������� �� ���� ± SD, as analyzed via analysis of variance and Student's t-test, and processed using the statistical software SPSS 13.0. Statistical significance was defined as P<0.05. Brachyury and SOX2 shRNA inhibit cell invasion. W� ��x� �����z�� ��� �ff��� �f Brachyury �� SOX2 k���k��w� �� ���� invasiveness in vitro using our previously reported tumor-cell dissemination assay (25) . In this assay, invasion of carcinoma cells is visualized as small green fluorescent spots escaping f��� � ���� p����� ���� ������ ��� p������ ������ ����. Therefore, we evaluated cancer cell invasion by the number of invasive cells and their distance from the artificial primary cancer nest. As shown in Fig. 3B , ACCS-M GFP cells demonstrated aggressive cell invasion into artificial stromal tissue. Invasiveness of ACCS-M GFP cells was strongly inhibited by k���k��w� �f Brachyury (Fig. 3C) or SOX2 (Fig. 3D) . shRNA ( Fig. 5 and Table I ). Relative IC 50 values (ACCS-M GFP=1) of Brachyury shRNA were ~0.33 (docetaxel) to 0.85 ���������� C ��� b���������, ��� ����� �f SOX2 ��RNA were 0.59 (bestatin) to 1 (paclitaxel, mytomycin C, and bleomycin). However, with the exception of bestatin, the degree of reduction did not reach parental ACCS GFP levels (Table I) . W� ��u�� ��� ��������� �� IC 50 f�� ���p�����, b���u�� ACCS ���� ����� ���w�� ������ ����������, ��� ��� ��x��u� ���� �f etoposide (1,000 µM) did not reduce cell viability to 50%. k���k��w� ��������� ��� �xp������� �f ���� ��� SLC �����-p����� ����, SLC19A1 �F��. 6B�.
Results
Brachyury
Brachyury and SOX2 shRNA induce radiosensitivity in vitro.
Cancer stem cells are insensitive to radiation. We analyzed T�b�� I. M���u��� IC 50 �µM� �f ���� ���������� ��u�. be effective for inhibiting cancer metastasis. It remains to be ���������� w������ Brachyury k���k��w� �� p��-�x������ cancer reduces the invasiveness of CSCs in the primary nest and increases their sensitivity to chemo-and radiotherapy. Cellular invasiveness and migration were markedly ������ �� ACCS-M GFP ���� �� ACCS GFP �����. Brachyury knockdown completely inhibited cellular invasiveness and ���������, w���� SOX2 knockdown did not. Activation of cellular invasiveness is an important characteristic of EMT. M����x �������p���������� �MMP�� ��� up���u����� �� EMT and induce cellular invasion of cancer cells (30) (31) (32) . Moreover, EMT-related MMP-9 upregulation degrades cellsurface E-cadherin (33) , an important phenotype of EMT. T�u�, Brachyury k���k��w� ����b���� ��� ���� �u������-nicity and metastasis, but also cancer cell invasion at the primary site. This finding suggests that Brachyury knockdown can inhibit cancer cell invasiveness of pre-existing �������.
CSC� ��� ��������������. S��������, ACCS-M GFP ����� ������������ ���������� �� ��� ������ ���������� ��u�� �x��p� b��������. T�� ��������� u��������� ��������������� involves drug transporters. Genetic variations in efflux �����p������ �f ��� ABC f�����, �u�� �� ABCB1 �MDR1, P-�����p�������, ABCC1 �MRP1�, ABCC2 �MRP2�, ��� ABCG2 �BCRP�, ��� up��k� �����p������ �f ��� SLC f�����, �u�� �� SLC19A1 �RFC1� ��� SLCO1B1 �SLC21A6�, ��� implicated in resistance to chemotherapy (34, 35) . We found ���� ������ ��� ABC f����� ����� w��� �xp������ �� ������ levels in ACCS-M GFP than in ACCS GFP cells, and this ��ff������ �� �xp������� ��� u������� ��� ��������������� �f ACCS-M GFP cells. However, the degree of upregulation of ����� ����� w�� ��� ����� �~5-15%�, �u�������� ���� ������� ��u���� f����� u�������� ��� ��������������� �f ACCS-M GFP.
Brachyury ��� SOX2 k���k��w� ����b���� ��� �xp������� �f ABC f����� �����. T�� SOX2 ���� �������� ABCC3 ��� ABCC6 �xp������� ����u�� ������ ��������p������ ���u��-tion (36) . Brachyury k���k��w� ����b���� SOX2 �xp�������. T����f���, Brachyury ��� ���������� ����b�� ABC �����-p����� ����� �����u�� SOX2 ��w����u������. B� ��������, SLC f����� ����� w��� up���u����� �� ACCS-M GFP �����, �u�������� ���� ��u� up��k� ���� ������ ����� �� ���u��� �� ACCS-M GFP cells. This finding contradicts the observed chemoresistance of ACCS-M GFP. However, only SLC19A1 (RFC1), the most relevant gene in chemoresistance (37, 38) , w�� ��������� �� ACCS-M GFP �����, w���� ��������� ���� ��u� up��k� w�� ����b����. Fu���������, Brachyury k���k-down recovered expression of SLC19A1 (RFC1) to its level �� ACCS GFP �����, ���������� ���� Brachyury k���k��w� ���u��� ��u� up��k�.
A������ p����b�� �xp�������� f�� ��� ��u� ���������� �f CSC� �� ��� �������������� p��p������ �f CSC� �� ���� ����� of the cell cycle, because various anticancer drugs are cell cycle-dependent. CSCs have a significantly higher proportion of cells in the G2-phase of the cell cycle (39) . Bleomycin, a �����p�p���� ����b����� w��� � u��qu� ��������� �f �����u��� activity, has G2-phase-specific cytotoxicity (40 Cancer stem-like cells are relatively radioresistant owing to ��������� ��� �x������� f������, ����u���� qu��������, ���������-���p���� ���������� ��.�., �������� DNA ��p���, up���u����� ���� �����-������� ����������, ��� ��������� f���-������� scavengers), and a microenvironment that enhances cell survival mechanisms (e.g., hypoxia and interaction with stromal ��������� �44�. T����f���, ��� ���� ���������� �f ���� ����� ���u������ u��������� ��������������� �f ACCS-M GFP �� CSC� ��� ������bu�� �� ��������������� ��� ��� ������������z��� �ff��� �f Brachyury k���k��w�. I� ��������� b������, ����� �� the late S-phase are especially resistant, and cells in the G2/Mphase are the most sensitive, to ionizing radiation (45) . CSCs in the breast cancer cell line MDA-MB231 are shifted to the S-��� G2-p����� ��� ��� ��������������. C����� D ��� E p������ levels are consistent with this profile, suggesting the involve-���� �f ��������u� �����b������� ��p��� �� ��� �������������� p������p� �46�. T����f���, ���� ����� ���u������ �� ACCS-M GFP ����� ��� b� � k�� f����� u��������� ���������������. T��� mechanism is an important area of future investigation.
C���������, CRT ��� �u�����u� ����������p� ���u�� cancer cell viability by complementarily targeting cellular vulnerabilities. However, CSCs survive these treatments, b���u�� ���� �� ��� ������ CSC ���� ����� ���u������. A� ���w� in Fig. 8 , Brachyury knockdown significantly enhanced the �ff��� �f CRT in vitro f�� ��� ������ ���������� ��u�� �� w���� ����� w��� ��������� �� � ������ ��u�. T���� ���� �upp��� ��� conclusion from our previous study that Brachyury k���k-��w� f����b�� ��ff���������� CSC�, ��u���� ���� �� ���� ����� ��������. Fu���������, ��� �ff��� �f Brachyury k���k��w� was significantly stronger than that of SOX2, a conventional ���� ���� ���u������ ����. Mu���p�� ���u������ ����� ��� believed to regulate cell stemness. However, we have shown ���� k���k��w� �f � ������ ����, Brachyury, �������� �u���p�� ���u������ ����� ���u������u���. H����, Brachyury k���k-��w� ��� b� �� ��p������ �����p�u��� �pp����� ��� ���u�� be further investigated for clinical use.
In conclusion, this study presents evidence that Brachyury knockdown reduces the invasiveness and chemo-and radio-���������� �f CSC� in vivo ��� �u������ ���� Brachyury k���k��w� �� � u��fu� �����p�u��� ���� f�� �������z��� CSC� �� conventional chemoradiotherapy.
